MedPath

Conservative Pulp Therapy of Primary Molars Using TheraCAL

Phase 3
Completed
Conditions
Reversible Pulpitis
Interventions
Drug: Dual cured resin modified tricalcium silicate cement
Registration Number
NCT04167943
Lead Sponsor
Ain Shams University
Brief Summary

The study is a clinical trial that assesses the clinical and radiographic success rates of 3 conservative pulp therapy treatments in primary molars compared to conventional pulpotomy using a bioactive dual cured calcium silicate cement (TheraCAL PT).

Detailed Description

Participating Children will be recruited from the outpatient's clinic of pediatric dentistry department , Faculty of Dentistry Ain Shams University and will be allocated to one of the following groups; Indirect pulp capping, direct pulp capping, partial pulpotomy or pulpotomy. TheraCAL PT, a dual cured tricalcium silicate cement will be used in all groups as the pulp capping material. Children will be followed every 6 months for a period of 1 year to evaluate clinical and radiographic success.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
216
Inclusion Criteria
  • Four to six years old healthy children
  • Cooperative (frankle scale + and ++)
  • With at least one vital and restorable primary molar with deep caries.
Read More
Exclusion Criteria
  • History of spontaneous pain, swelling, or sinus tract
  • Pathological mobility
  • pain on percussion
  • Furcation or periapical radiolucency
  • Internal or external pathological root resorption
  • Widening of periodontal membrane space
  • Discontinuity of lamina dura.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
indirect pulp cappingDual cured resin modified tricalcium silicate cementTheraCAL PT will be applied to affected dentin covering the pup.
Direct pulp CappingDual cured resin modified tricalcium silicate cementTheraCAL PT will be applied to pinpoint pulp exposures surrounded by sound dentin.
Partial PulpotomyDual cured resin modified tricalcium silicate cementPulp exposure will be enlarged to a depth of 1-3 mm by a sterile round diamond bur, and then TheraCAL PT will applied after hemostasis.
pulpotomyDual cured resin modified tricalcium silicate cementcomplete removal of coronal pulp tissue will be attempted if bleeding persisted after attempting Partial pulpotomy for exposures that are not eligible for DPC. TheraCAL PT will be applied thereafter, after achieving hemostasis.
Primary Outcome Measures
NameTimeMethod
Changes in Visual and tactile clinical examinationevery 6 months

Teeth will examined for any clinical signs of irreversible pulpitis or pulp necrosis

Secondary Outcome Measures
NameTimeMethod
Change in Dental Periapical Radiographic examinationevery 6 months

Teeth will be examined for any radiographic signs of pulp necrosis

Trial Locations

Locations (1)

Faculty of Dentistry, Ain Shams University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath